MeasuringSuccess

Key findings from the 2-year evaluation

Substantial implementation activity is underway

Progress is characterised by strong sector engagement and support for the Plan, increasing alignment of sector activities to the Plan’s priorities, and the establishment of enabling infrastructure to support longer-term system change and intended outcomes.

At least 333 initiatives are underway across the sector

Activity is strongest in prevention and early detection, consumer experience, and system foundations, reflecting the Plan’s early emphasis on establishing frameworks and enabling infrastructure. Workforce and Aboriginal and Torres Strait Islander equity demonstrate important early progress but require further scaling and sustained effort.

The Plan is functioning as a unifying national framework

This is strengthening alignment between jurisdictions and sectors, shaping policy priorities, and supporting collaboration. It is also influencing organisational strategies, funding bids, and planning processes, with alignment to the Plan increasingly seen as a marker of credibility and strategic relevance.

Elevation of equity

The Plan has moved equity — particularly Aboriginal and Torres Strait Islander cancer outcomes — from a principle dependent on individual leadership to a shared system-wide priority. This shift is evident in policy, funding, workforce development and service planning, supported by Indigenous-led initiatives and partnerships.

Changes at the service and patient level are less visible at this stage

A lag between system-level reform and improvements in frontline delivery and outcomes, is to be reasonably expected at this stage of a 10-year reform agenda, where system-level foundations typically precede measurable frontline change. This is an issue warranting attention as the Plan moves toward its 5-year mark, when service-level change and outcomes should become more evident.

Established implementation model, including implementation partnerships

A distributed implementation model has been established, based on shared responsibility across governments, the cancer sector, and implementation partners. Governance and coordination mechanisms — including 36+ Implementation Partnerships (as of June 2026), advisory structures and engagement processes — are supporting collaboration, although many are still maturing.

Australian Cancer Plan 2-year Evaluation at a Glance

At two years, the Plan has established strong national foundations, sector alignment and enabling infrastructure for the next phase of implementation.

WHAT HAS BEEN ESTABLISHED AT 2-YEARS

  • National policy frameworks in data, optimal care and genomics.
  • 36+ implementation partnerships.
  • Australian Comprehensive Cancer Network, with over 1,500 members.
  • Aboriginal and Torres Strait Islander-led equity initiatives.

EARLY SYSTEM EFFECTS

  • Stronger national alignment.
  • Policy and planning influence.
  • New sector collaboration.
  • Equity elevated as a shared priority.

IMPLEMENTATION ACTIVITY

333 initiatives underway across government and implementation partners

  • Strongest activity areas: Activity is strongest in prevention and early detection, consumer experience, data, research and system foundations.
  • Areas requiring further scaling: Workforce and Aboriginal and Torres Strait Islander equity show important early progress with further scaling and sustained effort required.

enablers

  • Shared national direction: The Plan provides an authorising framework that aligns governments, jurisdictions and sector partners around common priorities.
  • Cancer Australia leadership: Cancer Australia’s national coordinating role is supporting engagement, partnerships and policy coherence.
  • Foundational infrastructure: National frameworks in data, genomics and optimal care pathways are creating the policy architecture for consistent implementation.
  • Sector engagement and partnerships: Implementation partnerships, advisory structures and the Australian Comprehensive Cancer Network are strengthening collaboration and shared ownership.
  • Equity focus: Aboriginal and Torres Strait Islander-led initiatives have elevated equity as a shared system priority and strengthened First Nations leadership in cancer control.

barriers

  • Implementation capacity: Workforce pressures and organisational capacity constraints are limiting the pace and scale of delivery.
  • Funding constraints: Funding is not always sufficient, sustained or coordinated, limiting implementation at scale.
  • Data limitations: Current data systems provide useful activity-level information but are not yet sufficient to measure reach, scale or impact.
  • Governance complexity: Australia’s federated system creates challenges for role clarity, coordination and accountability across governments and partners.
  • Equity implementation challenges: Aboriginal and Torres Strait Islander stakeholders face high consultation demand, limited sector capacity and resourcing pressures relative to expectations.

NEXT PHASE PRIORITIES

SHARPEN IMPLEMENTATION FOCUS

  • Prioritise high-impact actions.
  • Define success measures.
  • Clarify roles.
  • Strengthen accountability.

BUILD system capability

  • Strengthen data infrastructure.
  • Invest in optimal care.
  • Enhance practical implementation support.
  • Build workforce capacity.

TRANSLATE FOUNDATIONS INTO IMPACT

  • Embed equity.
  • Sustain consumer engagement.
  • Scale national frameworks, partnerships and initiatives.

The Plan has established the foundations needed for long-term reform. The next phase is about translating those foundations into coordinated implementation at scale, clearer accountability and measurable progress toward the 5 year goals.

Australian Cancer Plan: implementation activity by action

Strategic Objective 1: Maximising Cancer Prevention & Early Detection

Embedding

Implementation activity is particularly strong across prevention, risk reduction and early detection actions. Stakeholders are actively contributing through initiatives that support cancer prevention, screening participation, early diagnosis and public awareness. The breadth of activity suggests strong alignment with the Plan's ambition to reduce cancer incidence and improve outcomes through earlier detection.

2-year actions

Embedding
Advancing
Advancing
Advancing
Advancing

5-year actions

Emerging
Emerging
Emerging
Established
Emerging

Strategic Objective 2: Enhanced Consumer Experience

Embedding

A substantial volume of initiatives aligns with actions focused on consumer experience, supportive care, treatment pathways and person-centred care. Activity demonstrates strong commitment across the sector to improving cancer outcomes and experiences for people affected by cancer.

2-year actions

Embedding
Embedding
Embedding

5-year actions

Emerging
Emerging
Emerging

Strategic Objective 3: World-Class Health Systems

Advancing

Implementation activity is evident across actions supporting high-quality, coordinated and sustainable cancer care. Stakeholder initiatives demonstrate ongoing efforts to strengthen health system performance, service integration and quality improvement.

2-year actions

Established
Established
Embedding
Embedding
Emerging

5-year actions

Advancing
Established
Advancing
Not yet commenced

Strategic Objective 4: Strong & Dynamic Foundations

Embedding

Strong momentum is evident across actions relating to data, research, digital health, innovation and knowledge generation. Activity under this Strategic Objective reflects significant sector investment in the foundations required to support continuous learning and future system improvement.

2-year actions

Established
Embedding
Embedding
Advancing

5-year actions

Advancing
Advancing
Emerging
Not yet commenced

Strategic Objective 5: Workforce to Transform Care

Advancing

Workforce-related initiatives are contributing to capability development, workforce planning and workforce sustainability. Activity demonstrates important progress in foundational workforce actions while highlighting opportunities to deepen implementation over the next phase of the Plan.

2-year actions

Advancing
Embedding
Advancing
Advancing

5-year actions

Emerging
Embedding
Emerging
Emerging

Strategic Objective 6: Aboriginal & Torres Strait Islander Equity

Advancing

Foundational activity is evident across initiatives supporting Aboriginal and Torres Strait Islander leadership, culturally safe care and equity-focused reform. Continued investment and implementation will support progress towards longer-term equity objectives across the Plan.

2-year actions

Advancing
Emerging
Advancing

5-year actions

Emerging
Advancing

Legend

Established
Foundational framework or key deliverables have been developed and are in place.
Embedding
Implementation activity is becoming established and integrated into routine practice, systems or processes. Ongoing refinement and improvement continue.
Advancing
Implementation is progressing strongly, with demonstrated activity, growing capability and increasing momentum.
Emerging
Implementation activity is underway, with initial evidence of progress, commitment and supporting structures emerging.
Not yet commenced
No implementation activity has commenced, or no relevant activity has been identified.
Actions that contribute to Aboriginal and Torres Strait Islander cancer equity.

This visual shows the breadth and relative volume of implementation activity mapped to each action in the Australian Cancer Plan, based on initiative data reported by stakeholders across the cancer control sector, including the Australian Government, state and territory governments, Implementation Partners of the Australian Cancer Plan, non-government and professional organisations, and Aboriginal and Torres Strait Islander organisations. Reporting is voluntary and evolving, and a single initiative may map to more than one action. The visual reflects activity reported to date and should be read as an indication of implementation activity across the sector contributing to the Plan. It does not assess the scale, quality, reach or impact of initiatives, or completion of actions.

KEY EVALUATION QUESTION GROUPINGS

The eight Key Evaluation Questions in the Monitoring and Evaluation Framework have been grouped into five thematic categories to support synthesis and reporting of evaluation findings.

Strengthening implementation

Implementation at scale

The Plan has established a strong and credible foundation for long-term reform. The next phase requires a deliberate shift toward implementation at scale, supported by stronger capability, clearer accountability and sustained investment, to ensure that early system-level progress delivers measurable improvements in cancer outcomes and experiences for all Australians.

Resourcing

While there is strong support for the Plan, stakeholders consistently identified limited funding, workforce pressures, data challenges and governance complexities as barriers to progress. A deliberate shift is needed from establishing broad strategic directions to prioritising and resourcing delivery on the ground, with clear measures of success.

Coordination

There is an opportunity to sharpen implementation focus by prioritising high-impact actions and strengthening coordinated delivery across governments and implementation partners. Greater clarity of roles, responsibilities and accountability, supported by Cancer Australia’s ongoing leadership, would strengthen coordination across the cancer control sector.

Coordinated implementation has the potential to reduce duplication and fragmentation and address gaps in the system. This includes an ongoing emphasis on exploring how the Plan, the Aboriginal and Torres Strait Islander Cancer Plan, and state and territory cancer plans complement one another as each mature and are delivered. In this context, monitoring and evaluation systems should continue to mature so future reporting can better assess reach, scale and impact across the full system.

Further engagement

While acknowledging the fundamental complexity of Australia’s federated system, there would be benefit in further engagement between the Commonwealth, state and territory governments, sector partners and the broader cancer control sector. Stakeholders also highlighted the importance of ongoing consumer engagement to increase visibility of the Plan and ensure lived experience continues to inform implementation and future evaluation.

Policy levers and accountability

Strengthening policy levers and accountability mechanisms could further embed the Plan’s priorities across the cancer control system and support consistent uptake of key activities.This needs to be supported by sustained investment in system capability to enable implementation at scale. This includes strengthening data infrastructure, workforce capacity and practical supports to translate national frameworks into consistent delivery across the system. In particular, continued support for Aboriginal and Torres Strait Islander leadership and key First Nations cancer measures is needed to sustain momentum and drive more equitable outcomes.

Scale existing national frameworks

There are opportunities to build on and scale existing national frameworks, partnerships and initiatives. Continued implementation and integration of key frameworks and programs — including data, genomics, optimal care pathways and national networks — will be critical to translating early foundations into system-wide impact.

download and explore

Coming soon - Australian Cancer Plan 2-year Evaluation Full Report. If you would like an advanced copy of the report, please contact australiancancerplan@canceraustralia.gov.au

HOW WE EVALUATED

Guided by the Australian Cancer Plan Monitoring and Evaluation Framework, the evaluation was led by Cancer Australia using a hybrid model that included an independent external evaluation team from the University of Melbourne to provide evaluation expertise. Governance arrangements included an Australian Cancer Plan 2-year Evaluation Expert Advisory Group, and oversight through existing Cancer Australia advisory structures, supporting methodological rigour, transparency and sector confidence.

Information to inform the evaluation was gathered from multiple data sources including implementation documentation and monitoring data, an online stakeholder survey, and targeted stakeholder consultations conducted from February - March 2026. Findings were analysed to identify consistent themes across stakeholder perspectives and data sources, while acknowledging variation in experience across stakeholder groups.

Stakeholder engagement to inform the evaluation included 82 unique stakeholders across 39 consultation sessions and 57 survey responses, including governments, the cancer control sector, Aboriginal and Torres Strait Islander stakeholders and consumers.